BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11443855)

  • 1. Multiple endocrine neoplasia type 2: molecular aspects.
    Mulligan LM
    Front Horm Res; 2001; 28():81-102. PubMed ID: 11443855
    [No Abstract]   [Full Text] [Related]  

  • 2. [From gene to disease; from the RET gene to multiple endocrine neoplasia types 2A and 2B, sporadic and familial medullary thyroid carcinoma, Hirschsprung disease and papillary thyroid carcinoma].
    Hofstra RM; van der Luijt RB; Lips CJ
    Ned Tijdschr Geneeskd; 2001 Nov; 145(46):2217-21. PubMed ID: 11757244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic basis of endocrine disease: multiple endocrine neoplasia type 2.
    Mulligan LM; Ponder BA
    J Clin Endocrinol Metab; 1995 Jul; 80(7):1989-95. PubMed ID: 7608246
    [No Abstract]   [Full Text] [Related]  

  • 4. [One gene--four diseases: on the importance of mutations in the ret gene in MEN 2A, MEN 2B, Hirschsprung disease and medullary thyroid carcinoma].
    Fehmann HC; Göke B
    Z Gastroenterol; 1994 Jul; 32(7):416-7. PubMed ID: 7975780
    [No Abstract]   [Full Text] [Related]  

  • 5. Biological properties of Ret with cysteine mutations correlate with multiple endocrine neoplasia type 2A, familial medullary thyroid carcinoma, and Hirschsprung's disease phenotype.
    Ito S; Iwashita T; Asai N; Murakami H; Iwata Y; Sobue G; Takahashi M
    Cancer Res; 1997 Jul; 57(14):2870-2. PubMed ID: 9230192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RET mutations in multiple endocrine neoplasia type 2 and Hirschsprung disease.
    Reynolds LF; Eng C
    Curr Opin Pediatr; 1995 Dec; 7(6):702-9. PubMed ID: 8776023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and hirschsprung disease.
    Eng C; Mulligan LM
    Hum Mutat; 1997; 9(2):97-109. PubMed ID: 9067749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RET proto-oncogene in the development of human cancer.
    Eng C
    J Clin Oncol; 1999 Jan; 17(1):380-93. PubMed ID: 10458257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple endocrine neoplasia type 2: recent progress in diagnosis and management.
    Heshmati HM; Hofbauer LC
    Eur J Endocrinol; 1997 Dec; 137(6):572-8. PubMed ID: 9437218
    [No Abstract]   [Full Text] [Related]  

  • 10. The RET proto-oncogene: a challenge to our understanding of disease pathogenesis.
    Kusafuka T; Puri P
    Pediatr Surg Int; 1997; 12(1):11-8. PubMed ID: 9035202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RET oncogene.
    Mak YF; Ponder BA
    Curr Opin Genet Dev; 1996 Feb; 6(1):82-6. PubMed ID: 8791480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C618R mutation in exon 10 of the RET proto-oncogene in a kindred with multiple endocrine neoplasia type 2A and Hirschsprung's disease.
    Caron P; Attié T; David D; Amiel J; Brousset F; Roger P; Munnich A; Lyonnet S
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2731-3. PubMed ID: 8675603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RET activation by germline MEN2A and MEN2B mutations.
    Borrello MG; Smith DP; Pasini B; Bongarzone I; Greco A; Lorenzo MJ; Arighi E; Miranda C; Eng C; Alberti L
    Oncogene; 1995 Dec; 11(11):2419-27. PubMed ID: 8570194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ret protooncogene mutations and endocrine neoplasia--a story intertwined with neural crest differentiation.
    Gagel RF
    Endocrinology; 1996 May; 137(5):1509-11. PubMed ID: 8612478
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular mechanisms of development of multiple endocrine neoplasia 2 by RET mutations.
    Takahashi M; Asai N; Iwashita T; Murakami H; Ito S
    J Intern Med; 1998 Jun; 243(6):509-13. PubMed ID: 9681851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes and Hirschsprung disease.
    Smith DP; Eng C; Ponder BA
    J Cell Sci Suppl; 1994; 18():43-9. PubMed ID: 7883791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The physical map of the human RET proto-oncogene.
    Pasini B; Hofstra RM; Yin L; Bocciardi R; Santamaria G; Grootscholten PM; Ceccherini I; Patrone G; Priolo M; Buys CH
    Oncogene; 1995 Nov; 11(9):1737-43. PubMed ID: 7478601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The RET C620S mutation causes multiple endocrine neoplasia type 2A (MEN2A) but not Hirschsprung disease (HSCR) in a family cosegregating both phenotypes.
    Fernández RM; Antiñolo G; Eng C; Borrego S
    Hum Mutat; 2003 Nov; 22(5):412-5. PubMed ID: 14517954
    [No Abstract]   [Full Text] [Related]  

  • 19. Putting the bits and pieces of the RET proto-oncogene puzzle together.
    Gagel RF
    Bone; 1995 Aug; 17(2 Suppl):13S-16S. PubMed ID: 8579892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma.
    Marsh DJ; Mulligan LM; Eng C
    Horm Res; 1997; 47(4-6):168-78. PubMed ID: 9167949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.